Procter & Gamble Co (PG)
P&G (PG) Is Considered a Good Investment by Brokers: Is That True?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Procter & Gamble: Resilient Business Facing Growth Headwinds
Procter & Gamble remains a hold for me, with a $165 price target, due to revenue stagnation despite its strong dividend history. The 68-year streak of dividend growth and a 2.69% yield make PG attractive for income-focused, risk-averse investors seeking steady quarterly payouts. PG trades at a premium valuation, justified by its high-quality, defensive business model, but overvaluation risks persist if growth doesn't re-accelerate.
Procter & Gamble: A Diaper Of A Deal At This Price
Procter & Gamble's growth has slowed, with weak cash flow and operational metrics not matching its earnings and sales performance. Despite its defensive profile and dividend history, current valuation multiples are too high given the lack of meaningful growth re-acceleration. My DCF analysis suggests a 32% downside to fair value, with current prices only justified by unrealistic 10% growth assumptions.
Here's Why Procter & Gamble (PG) Fell More Than Broader Market
In the closing of the recent trading day, Procter & Gamble (PG) stood at $156.15, denoting a -1.59% move from the preceding trading day.
Procter & Gamble Exhibits High P/E: A Buy Opportunity or Time to Wait?
PG posts solid growth and dividend strength, but its high valuation sparks debate on whether the stock is worth buying now.
Here is What to Know Beyond Why Procter & Gamble Company (The) (PG) is a Trending Stock
Zacks.com users have recently been watching P&G (PG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
PG vs. Inflation: How Long Can Price Hikes Offset Input Costs?
Procter & Gamble faces slowing category growth as inflation and tariffs challenge its long-running price hike strategy.
Procter & Gamble's Margins Stay Firm: Is Premiumization Paying Off?
PG expands core margins and grows EPS despite volatility, signaling the strength of its premiumization strategy.
Procter & Gamble Company (The) (PG) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to P&G (PG). This makes it worthwhile to examine what the stock has in store.
Procter & Gamble: The Outlook Is Worrying (Rating Downgrade)
Procter & Gamble's Q4 showed sluggish top-line growth but resilient business activity, with organic sales up just 2% year-over-year. Profitability improved through operating margin gains, driving healthy EPS growth, but future guidance signals a slowdown to 2% EPS growth in FY2026. Valuation remains unattractive, with the forward P/E still at a significant premium to the sector despite recent contraction and weak growth outlook.
Procter & Gamble Q4 Earnings: Deceleration Of Market Growth Continues
I reiterate my buy rating on The Procter & Gamble Company, setting a fair value of $180 per share despite weak near-term consumer demand. Q4 FY25 results show 2% organic revenue and 6% core EPS growth, with limited pricing power offsetting flat volume growth. Leadership transition and a 7,000-job restructuring should drive long-term efficiency, though near-term uncertainties remain.
P&G Plans Price Hikes as Shoppers Grow ‘More Careful'
Consumer packaged goods giant Procter & Gamble (P&G) is raising prices amid growing consumer caution. The company released earnings Tuesday (July 29) showing a 2% increase in net sales, while also introducing guidance for its next fiscal year included a $1 billion hit based on projections of higher costs from tariffs.
